GROUPAMA ASSET MANAGMENT

Position in GILD — Gilead Sciences, Inc.

CIK 1055969 PARIS, I0

Position in GILD

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$5,294,666

-$993,304 QoQ

Shares Held

37,990

-25.8% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 20.028954988154776.ToString("F0")% Shared 0.ToString("F0")% None 79.97104501184522.ToString("F0")%

Healthcare · as of Mar 31, 2026

GROUPAMA ASSET MANAGMENT holds $418,001,230 across 10 Drug Manufacturers - General names. GILD ranks #6 (1.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AZN	Astrazeneca PLC	863,629	$170,324,911
2	MRK	Merck & Co., Inc.	874,963	$105,249,299
3	LLY	ELI LILLY & Co	95,376	$87,723,983
4	ABBV	AbbVie Inc.	156,150	$33,961,063
5	JNJ	Johnson & Johnson	22,693	$5,547,076
6	GILD	Gilead Sciences, Inc. This page	37,990	$5,294,666
7	AMGN	Amgen Inc	14,960	$5,263,676
8	PFE	Pfizer Inc	63,889	$1,794,003

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,294,666	37,990	-25.8%	Shares	Sole	2026-05-22
2025-12-31	$6,287,970	51,230	-2.0%	Shares	Sole	2026-02-27
2025-09-30	$5,803,191	52,281	+47.5%	Shares	Sole	2025-12-01
2025-06-30	$3,928,456	35,433	-26.1%	Shares	Sole	2025-08-13
2025-03-31	$5,369,996	47,925	-11.5%	Shares	Sole	2025-05-14
2024-12-31	$5,003,867	54,172	-9.8%	Shares	Sole	2025-02-12
2024-09-30	$5,034,004	60,043	+71.1%	Shares	Sole	2024-11-15
2024-06-30	$2,407,319	35,087	-12.0%	Shares	Sole	2024-08-14
2024-03-31	$2,920,843	39,875	-35.9%	Shares	Sole	2024-05-14
2023-12-31	$5,043,358	62,256	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.